The article highlights ResMed's exceptional performance over the past 15 years, showcasing its ability to generate significant returns for investors. This historical performance, especially the impressive average annual return of 15.8%, is likely to positively influence investor sentiment and could lead to increased interest in RMD stock in the short term. The mention of ResMed's substantial market capitalization further solidifies its position as a strong and stable company in the eyes of investors.